Grisar JC, Haddad F, Gomari FA, et al. Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from bio-marker to therapeutic agent[J].Biomark Med,2011,5 ( 6) :731-744．
[2]
OE, Lee BH, Ahn HY, et al. Efficient non adhesive ex vivo expansion of early endothelial progenitor cells derived from CD34 + human cord blood fraction for effective therapeutic vascularization[J].FASEB J, 2011, 25(1):159-169.
[3]
Inoue T, Croce K, Morooka T, et al．Vascular inflammation and repair: implications for re-endothelialization,restenosis,and stent thrombosis[J].JACC Cardiovasc Interv, 2011,4(10):1057-1066．
Yanmin Zhang, Brittney-Shea Herbert, Gangaraju Rajashekhar, et al. Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway[J].FASEB J,2009, 23: 1358-1365.
[6]
Hiroko Fujii, Shu-Hong Li, Paul E, et al. C-Reactive Protein Alters Antioxidant Defenses and Promotes Apoptosis in Endothelial Progenitor Cells[J].Arterioscler Thromb Vasc Biol, 2006,26:2476-2482.
[7]
Liu Yueli, Wang Liqun, Wu Haitao, et al. Comparison of anti-atherosclerotic effects of two different extracts from leaves of Mallotus furetianus[J].Asian Pacific Journal of Tropical Medicine, 2011,4(11)：878-882.
